MenAfriVac™, a vaccine developed through the Meningitis Vaccine Project (MVP) to protect against life-threatening meningococcal meningitis

MenAfriVac™, a vaccine developed through the Meningitis Vaccine Project (MVP) to protect against life-threatening meningococcal meningitis, received prequalification from the World Health Organization (WHO) on 23rd June 2010. The action clears the way for the phased introduction of the vaccine in Africa later this year.Read more »

Communicating MRC’s vaccine studies in Sukuta: Saihou Bobb (field assistant); Dr Katie Flanagan, Head of Infant Immunology Team, MRC (UK) The Gambia

On Thursday 29th April 2010, Sukuta Health Centre opened its doors to the community and other key stakeholders in a programme themed ‘Working Together with the Community: Novel Vaccine Studies’.Read more »